Cingulate Inc. Warrants
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch CINGW and buy or sell other stocks, ETFs, and their options commission-free!About CINGW
Cingulate, Inc. operates as a clinical stage bio pharmaceutical company using a Precision Timed Release drug delivery platform technology to build a pipeline of next-generation pharmaceutical products. The firm initially focused on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD).
CEOShane J. Schaffer, PharmD
CEOShane J. Schaffer, PharmD
Employees—
Employees—
HeadquartersKansas City, Kansas
HeadquartersKansas City, Kansas
Founded2013
Founded2013
Employees—
Employees—
CINGW Key Statistics
Market cap—
Market cap—
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume46.22K
Average volume46.22K
High today$0.059
High today$0.059
Low today$0.05
Low today$0.05
Open price$0.05
Open price$0.05
Volume18.10K
Volume18.10K
52 Week high$0.175
52 Week high$0.175
52 Week low$0.02
52 Week low$0.02
Stock Snapshot
The current Cingulate Inc. Warrants(CINGW) stock price is $0.06.
On 2025-12-17, Cingulate Inc. Warrants(CINGW) stock moved within a range of $0.05 to $0.06. With shares now at $0.06, the stock is trading +18.0% above its intraday low and 0.0% below the session's peak.
Trading activity shows a volume of 18.1K, compared to an average daily volume of 46.22K.
The stock's 52-week range extends from a low of $0.02 to a high of $0.18.
The stock's 52-week range extends from a low of $0.02 to a high of $0.18.